Adam Gregory explains why
the future looks so promising for adoptive immunotherapy following the recent agreement between the NHS and Novartis
View the original article here: UK NHS adopts CAR-T therapy
The article was originally posted on IPMagazine.
Each article is copyrighted to their original authors. We do not own any rights to the news or the images used. Whilst every care is taken to ensure that the news posts published are accurate, we cannot guarantee the authenticity of the news article on every occasion. There’s no copyright infringement intended. The news is for informational purposes only and does not provide legal advice.